Used as a chiral ligand in asymmetric catalysis, particularly in transition metal-catalyzed enantioselective reactions. Its structure enables high stereocontrol in hydrogenation and cross-coupling reactions, making it valuable in the synthesis of optically active pharmaceuticals and fine chemicals. The anthracenyl and trifluoromethyl groups enhance ligand rigidity and electron-withdrawing properties, improving catalytic efficiency and enantioselectivity. Commonly applied in ruthenium- or rhodium-based catalytic systems for the production of chiral intermediates in drug development.